(Q34189642)

31 July 2017

1 reference

title

Pharmacogenetics of human androgens and prostatic diseases (English)

1 reference

31 July 2017

Novelli G

1

1 reference

31 July 2017

Margiotti K

series ordinal

2

1 reference

31 July 2017

Sangiuolo F

series ordinal

3

1 reference

31 July 2017

Reichardt JK

series ordinal

4

1 reference

31 July 2017

publication date

1 February 2001

1 reference

31 July 2017

1 reference

31 July 2017

volume

2

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

65-72

1 reference

31 July 2017

cites work

Cancer statistics, 2000.

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

Medical therapy for benign prostatic hyperplasia: a review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

Epidemiologic evidence regarding predisposing factors to prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

Ethical issues in urology: the patient's perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

21 January 2018

Hormonal carcinogenesis

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

Molecular genetics of steroid 5 alpha-reductase 2 deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

Steroid 5 alpha-reductase: two genes/two enzymes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

Racial variation in prostate cancer incidence and in hormonal system markers among male health professionals

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

Biochemical and pharmacogenetic dissection of human steroid 5 alpha-reductase type II

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

Molecular genetics of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

Somatic mutations at the SRD5A2 locus encoding prostatic steroid 5alpha-reductase during prostate cancer progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

Molecular defects of the androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

Androgen receptor gene CAG repeat length varies in a race-specific fashion in men without prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

The CAG repeat within the androgen receptor gene and benign prostatic hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

Update of the androgen receptor gene mutations database

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

Glucocorticoids can promote androgen-independent growth of prostate cancer cells through a mutated androgen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

Two mutations identified in the androgen receptor of the new human prostate cancer cell line MDA PCa 2a.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

The androgen receptor in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

SIGNIFICANCE OF THE CAG REPEAT POLYMORPHISM OF THE ANDROGEN RECEPTOR GENE IN PROSTATE CANCER PROGRESSION

21 January 2018

1 reference

https://api.crossref.org/works/10.1517/14622416.2.1.65

21 January 2018

Identifiers

DOI

10.1517/14622416.2.1.65

1 reference

31 July 2017

1 reference